Cargando…
TNFAIP3 mutation is an independent poor overall survival factor for patients with T‐cell acute lymphoblastic leukemia
BACKGROUND: It is imperative to explore potential biomarkers for predicting clinical outcome and developing targeted therapies for T‐cell acute lymphoblastic leukemia (T‐ALL). This study aimed to investigate the mutation patterns of tumor necrosis factor‐alpha‐inducing protein 3 (TNFAIP3, also known...
Autores principales: | Chen, Cunte, Zhou, Lingling, Zhu, Lihua, Luo, Gengxin, Wang, Liang, Zeng, Chengwu, Zhou, Hongsheng, Li, Yangqiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972139/ https://www.ncbi.nlm.nih.gov/pubmed/36056685 http://dx.doi.org/10.1002/cam4.5196 |
Ejemplares similares
-
TNFAIP3 mutation may be associated with favorable overall survival for patients with T-cell lymphoma
por: Chen, Cunte, et al.
Publicado: (2021) -
High expression of TMEM244 is associated with poor overall survival of patients with T-cell lymphoma
por: Chen, Cunte, et al.
Publicado: (2022) -
Low Expression of CD5 and CD6 Is Associated with Poor Overall Survival for Patients with T-Cell Malignancies
por: Sui, Songnan, et al.
Publicado: (2022) -
Transcriptome-Based Co-Expression of BRD4 and PD-1/PD-L1 Predicts Poor Overall Survival in Patients With Acute Myeloid Leukemia
por: Chen, Cunte, et al.
Publicado: (2021) -
BCL11B Mutations Are Associated with Higher CD8+ T-Cell Percentage and Favorable Clinical Outcomes in Patients with T-Cell Acute Lymphoblastic Leukemia
por: Chen, Cunte, et al.
Publicado: (2023)